Preparation of a Klebsiella pneumoniae conjugate nanovaccine using glycol-engineered Escherichia coli

BACKGROUND: Engineered strains of Escherichia coli have been used to produce bioconjugate vaccines using Protein Glycan Coupling Technology (PGCT). Nanovaccines have also entered the vaccine development arena with advances in nanotechnology and have been significantly developed, but chassis cells fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yan, Pan, Chao, Wang, Kangfeng, Guo, Yan, Sun, YanGe, Li, Xiang, Sun, Peng, Wu, Jun, Wang, Hengliang, Zhu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163571/
https://www.ncbi.nlm.nih.gov/pubmed/37149632
http://dx.doi.org/10.1186/s12934-023-02099-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163571/
https://www.ncbi.nlm.nih.gov/pubmed/37149632
http://dx.doi.org/10.1186/s12934-023-02099-x

Ejemplares similares